Cargando…
European guidelines on managing adverse effects of medication for ADHD
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These relate to both relatively minor ad...
Autores principales: | Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., Holtmann, M., Hulpke-Wette, M., Lecendreux, M., Rosenthal, E., Rothenberger, A., Santosh, P., Sergeant, J., Simonoff, E., Sonuga-Barke, E., Wong, I. C. K., Zuddas, A., Steinhausen, H.-C., Taylor, E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012210/ https://www.ncbi.nlm.nih.gov/pubmed/21042924 http://dx.doi.org/10.1007/s00787-010-0140-6 |
Ejemplares similares
-
Erratum to: Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010) -
Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010) -
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
por: Danckaerts, Marina, et al.
Publicado: (2009) -
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020) -
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)